Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles. - Wikidata - awgldk - TriplyDB

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.

http://www.wikidata.org/entity/Q37624171

about

Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy.

P2860

Q47427120-395710CD-7BBA-4DBE-93D7-F647464A0444 Q51224172-2C039139-9357-4126-99CD-853D4E18DD3D

P2860

Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles.

http://www.wikidata.org/entity/Q37624171

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pathological Complete Remissio ...... erapy; Not the End of Battles.

@en

Pathological Complete Remissio ...... erapy; Not the End of Battles.

@nl

type

label

Pathological Complete Remissio ...... erapy; Not the End of Battles.

@en

Pathological Complete Remissio ...... erapy; Not the End of Battles.

@nl

prefLabel

Pathological Complete Remissio ...... erapy; Not the End of Battles.

@en

Pathological Complete Remissio ...... erapy; Not the End of Battles.

@nl

P1433

Q37624171-921B82C9-585E-491E-B6D4-3F130BE6DB51

P1476

Q37624171-FFF66F06-5251-4D7B-9CCF-E44FA278E2D5

P2093

Q37624171-0C86563E-11A2-4332-A391-68DE40262265

Q37624171-482A0B64-9338-4C52-A1D8-D97F418C1CCC

Q37624171-6977D811-A601-477F-903C-09DDDDE05FFC

Q37624171-731FE757-E121-4100-91A8-C0FE72586A8D

Q37624171-887EE14F-9994-4048-9488-2A05EA1FD0B5

P2860

Q37624171-00774BDC-1891-437B-BD07-F88F09F28407

Q37624171-00B54BD0-AA53-4E95-8FF8-71F97345E435

Q37624171-1E56641F-90DD-418C-88CA-7B40496C9CFA

Q37624171-22066047-9609-4877-944C-0B3277E8ED9E

Q37624171-5541D577-E4C2-4E6B-B13D-7D238EE9ACDF

Q37624171-60DBE21C-B850-49A6-96B0-FC48794C09DB

Q37624171-675B240A-FB3D-47F2-A306-8EAB93558E9E

Q37624171-77D41884-E2E2-4277-9DE5-F68E243B6A59

Q37624171-925F09D3-B82F-4F64-8355-F56516B2E488

Q37624171-AC889CD0-A5C3-4F72-AA28-F1A083A7BFBB

P304

Q37624171-CDBF7695-E839-423F-A67A-8ED3F06DC673

P31

Q37624171-4BA92502-4CC7-4DC9-9BE5-0F773AC53E43

P356

Q37624171-607047F0-CDCD-4A54-82BB-DF7E8BC12EA7

P407

Q37624171-FB312D9C-92A1-4769-A56C-BE1734D4BCF6

P433

Q37624171-FC1AB8F5-127D-48A2-A743-C5FFE0CED08D

P478

Q37624171-693BF261-6F21-46DD-8BFA-BDD28739FB00

P50

Q37624171-2296616A-891C-44BA-97CC-1E82DB6EB6E5

Q37624171-26AAE15F-73DE-4576-83DA-D1F67E5B5D07

Q37624171-4D7A47C6-2604-4148-BE74-0314E15782F6

P577

Q37624171-5590EF31-99ED-4D53-A1E1-5952FD249D9E

P698

Q37624171-2FAF02ED-E235-44B8-B487-E347979353AF

P921

Q37624171-33FEBCFB-BCA4-4EF9-B26B-32E419E42199

P932

Q37624171-6EB92E0D-B320-4674-8BA0-13C9670D83C0

P356

MD.0000000000002168

P1433

P1476

Pathological Complete Remissio ...... herapy; Not the End of Battles

@en

P2093

Hogeun Kim

http://www.w3.org/2001/XMLSchema#string

Jinsil Seong

http://www.w3.org/2001/XMLSchema#string

Myoung Jin Kim

http://www.w3.org/2001/XMLSchema#string

Sung Hwan Lee

http://www.w3.org/2001/XMLSchema#string

Woo Jung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

National trends in resection of the distal pancreas.

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.

Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.

Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer.

Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region.

Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.

P304

e2168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000002168

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

Ho Kyoung Hwang

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26717359

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5291600

http://www.w3.org/2001/XMLSchema#string